Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report)’s stock price crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.39 and traded as low as $0.25. Cell MedX shares last traded at $0.25, with a volume of 167 shares traded.
Cell MedX Trading Down 16.6 %
The business has a 50-day moving average of $0.39 and a 200-day moving average of $0.28.
Cell MedX Company Profile
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Read More
- Five stocks we like better than Cell MedX
- What is a Bond Market Holiday? How to Invest and Trade
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- How to Evaluate a Stock Before Buying
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
